Restart Life Sciences Corp. (CSE:HEAL)

Canada flag Canada · Delayed Price · Currency is CAD
0.100
0.00 (0.00%)
Feb 25, 2026, 2:09 PM EST
-9.09%
Market Cap 5.93M
Revenue (ttm) n/a
Net Income (ttm) -1.23M
Shares Out 59.25M
EPS (ttm) -0.05
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 13,000
Average Volume 30,907
Open 0.100
Previous Close 0.100
Day's Range 0.100 - 0.100
52-Week Range 0.045 - 0.140
Beta -1.02
RSI 45.43
Earnings Date Apr 8, 2026

About Restart Life Sciences

Restart Life Sciences Corp., through its subsidiaries, operates as a biotechnology company worldwide. It engages in developing natural remedies specifically tailored for individuals on the autism spectrum; health-related foods that promote both mind and body wellness for healthy living, as well as psilocybin clinical trial for fragile X syndrome. The company was formerly known as Nova Mentis Life Science Corp. and changed its name to Restart Life Sciences Corp. in November 2024. Restart Life Sciences Corp. was incorporated in 2004 and is based ... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2004
Country Canada
Stock Exchange Canadian Securities Exchange
Ticker Symbol HEAL
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.